Codexis

Codexis Gross Profit/Assets

The Gross Profit to Assets Ratio of Codexis (CDXS) as of Nov 10, 2026 is 41.31 %. In the previous year, Gross Profit to Assets Ratio was 28.90 % — a change of 42.95% (higher).

Gross Profit/Assets

41.31 %

YoY

42.95%

Last updated:

Gross Profit to Assets Ratio of Codexis is 2025 41.31 % . Gross Profit to Assets Ratio of Codexis was 2024 28.90 % . It decreases by 42.95% higher compared to the previous year.

The Codexis Gross Profit/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Profit/Assets
Date
Gross Profit/Assets
Jan 1, 2018
61.28 USD
Jan 1, 2019
35.44 USD
Jan 1, 2020
24.96 USD
Jan 1, 2021
33.50 USD
Jan 1, 2022
40.16 USD
Jan 1, 2023
41.98 USD
Jan 1, 2024
28.90 USD
Jan 1, 2025
41.31 USD
The Codexis Gross Profit/Assets history
YEARGross Profit/AssetsYoY
41.31 %+42.95%
28.90 %-31.18%
41.98 %+4.54%
40.16 %+19.87%
33.50 %+34.25%
24.96 %-29.58%
35.44 %-42.18%
61.28 %-7.94%
66.57 %-39.28%
109.64 %+38.99%
78.88 %+48.39%
53.16 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Codexis Stock analysis

What does Codexis do? Codexis Inc. is an American biotechnology company that specializes in developing innovative biological solutions for a variety of industries. The company was founded in 2002 and is headquartered in Redwood City, California. Business Model: Codexis is service-oriented and provides customized enzyme solutions for companies looking to improve their products through sustainable processes. The company has developed a unique platform called Rational Protein Engineering, which allows for the development of specific enzymes for various industries. Customers benefit from enzyme optimization expertise and know-how. Divisions: Codexis operates in the fields of life sciences, materials science, agrochemicals, and biofuels. 1. Life Sciences: Codexis specializes in the production of enzymes and biocatalysts for the pharmaceutical industry in the life sciences division. The goal is to provide a faster and more efficient manufacturing process for pharmaceutical active ingredients. The company has successfully developed active ingredients for antibodies, lipids, uric acid, and antivirals. 2. Materials Science: In the materials science division, Codexis specializes in the production of enzymes for materials such as dyes, polymers, and cosmetic products. Codexis ensures that these products are efficiently manufactured without the use of environmentally harmful chemicals. 3. Agrochemicals: Codexis offers customized enzyme solutions to agrochemical manufacturers that reduce the use of chemicals and benefit the environment. These enzymes help in the production of pesticides and other agrochemicals. 4. Biofuels: In the biofuels division, Codexis specializes in the production of enzymes for processing corn, harvested plants, or waste products. These enzymes help enable cost-effective biofuel production. Products: Codexis has developed a wide range of products tailored to the needs of various industries. Some of the products recently introduced to the market by Codexis include: 1. CodeEvolver: CodeEvolver is a platform that allows biotechnology companies to quickly create customized enzyme solutions for their specific needs. The process is fully automated and results in a significant reduction in development time and costs. 2. Codex® screening panels: Codexis offers various screening panels that allow customers to quickly and efficiently select the enzymes best suited for their purposes. The panels are suitable for industries including pharmaceuticals, chemicals, and plant protection. 3. Codex® enzymes: Codexis offers a wide range of enzymes specifically designed for different industry needs. This includes enzymes for the production of biofuels, pesticides, cosmetic products, and pharmaceuticals. Overall, Codexis Inc. has demonstrated its ability to deepen the understanding of biocatalysts and introduce innovative biological processes in a variety of industries through its unique Rational Protein Engineering platform. Codexis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Codexis stock

Gross Profit to Assets Ratio of Codexis is 41.31 % in 2025.

Gross Profit to Assets Ratio of Codexis changed from 28.90 % to 41.31 %, representing a 42.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Profit to Assets Ratio Codexis since 2006 – with annual values, charts, and detailed analysis.

Gross Profit/Assets measures how efficiently a company uses its assets to generate gross profit. Research shows it is a strong predictor of future stock returns.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Profit to Assets Ratio's Codexis with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Profit to Assets Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Profit to Assets Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Codexis

All Key Metrics — Codexis